Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Revenue: 2009-2024

Historic Revenue for Heron Therapeutics (HRTX) over the last 16 years, with Dec 2024 value amounting to $144.3 million.

  • Heron Therapeutics' Revenue rose 16.47% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.1 million, marking a year-over-year increase of 12.60%. This contributed to the annual value of $144.3 million for FY2024, which is 13.57% up from last year.
  • As of FY2024, Heron Therapeutics' Revenue stood at $144.3 million, which was up 13.57% from $127.0 million recorded in FY2023.
  • In the past 5 years, Heron Therapeutics' Revenue ranged from a high of $144.3 million in FY2024 and a low of $86.3 million during FY2021.
  • In the last 3 years, Heron Therapeutics' Revenue had a median value of $127.0 million in 2023 and averaged $126.3 million.
  • Per our database at Business Quant, Heron Therapeutics' Revenue plummeted by 39.28% in 2020 and then rose by 24.70% in 2022.
  • Over the past 5 years, Heron Therapeutics' Revenue (Yearly) stood at $88.6 million in 2020, then decreased by 2.59% to $86.3 million in 2021, then increased by 24.70% to $107.7 million in 2022, then increased by 17.99% to $127.0 million in 2023, then climbed by 13.57% to $144.3 million in 2024.